Clinical research - Press Releases

Date	Title	Company
12-Jan-2022	Parexel Recognized as “Top CRO to Work With” in WCG CenterWatch Global Site Relationship Benchmark Survey	Parexel
09-Jan-2022	Registration is open for SMi’s 5th Annual Pharmaceutical Microbiology East Coast 2022	SMi Group
07-Jan-2022	The Transdermal and Microneedle Drug Delivery Virtual Conference 2022 is now only 3 weeks away!	SMi Group
06-Jan-2022	WuXi STA Passes the First U.S. FDA Drug Product Pre-Approval Inspection at its Shanghai Waigaoqiao site	WuXi STA
05-Jan-2022	Emmes Acquires Institut Dr. Schauerte	Emmes
24-Dec-2021	CD ProGPCR Announces GPCR Gene Synthesis Services for Researchers	CD ProGPCR
24-Dec-2021	CD BioSignal Introduces Diabetes and Metabolism Solutions for Life Science Research	CD BioSignal
24-Dec-2021	Amerigo Scientific Launches KCC2 Ion Channel for Researchers	Amerigo Scientific
24-Dec-2021	STEMart Announces Sensitization Testing for Medical Device	STEMart
24-Dec-2021	CD Bioparticles Announces Offering of Polylactides for Researchers	CD Bioparticles
24-Dec-2021	CD Bioparticles Launches New Polystyrene Latex Beads to Accelerate Bioresearch	CD Bioparticles
23-Dec-2021	Creative Diagnostics Launches Immunohistochemistry Antibodies for Pathology Study	Creative Diagnostics
22-Dec-2021	IoM Hospice and digital health company leading clinical study to inform global dementia care	Memory Lane Games
21-Dec-2021	ProBioGen's GlymaxX® Technology Reaches Phase III Clinical Development	ProBioGen
20-Dec-2021	Advancing AI Drug Discovery in Clinical Trials at SMi’s 3rd Annual AI in Drug Discovery Conference	SMi Group
20-Dec-2021	SMi’s 10th Annual Pharmaceutical Microbiology UK Conference - A Virtual Conference with Online Access Only	SMi Group
16-Dec-2021	North-South MedTech Summit features healthcare and technology speakers across the UK	Empact Ventures
15-Dec-2021	Panthera leads the way in the UK with specialist research sites for NASH and NAFLD studies	Panthera Biopartners
15-Dec-2021	HUTCHMED Highlights HMPL-523 Clinical Data Presented at the 2021 ASH Annual Meeting	HUTCHMED
15-Dec-2021	Actimed Therapeutics Achieves Major Corporate Milestone - Initiation of first clinical study of new salt of S-pindolol (ACM-001.1)	Actimed Therapeutics